Oxcarbazepine
NDC 10135-798, Oxcarbazepine, suspension, from Marlex Pharmaceuticals, Inc.
- Product NDC
- 10135-798
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217782
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-798 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE300 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-798-41 | 10135079841 | 250 mL in 1 BOTTLE, GLASS (10135-798-41) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d3684d55-0564-4849-bdf6-b91f22a3e28c
Use it
Look up 10135-798 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-798 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-798. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.